Jakarta— The Center for Health Financing and Decentralization Policy (Pusjak PDK) of the Health Development Policy Agency (BKPK) of the Indonesian Ministry of Health (Kemenkes) together with Gadjah Mada University as the HTA agent and The Medicines, Technologies, and Pharmaceutical Services (MTaPS) USAID and implement Capacity Building Health Technology Assessment (HTA) with the theme of Modeling Method and Calibration of Economic Evaluation of Adjuvant Trastuzumab Administration for Early Stage HER2-positive Breast Cancer. This activity can be held with the support of World Health Organization (WHO).
This capacity building event was opened by the Pusjak PDK Kemenkes, represented by the Head of the HTA Policy Working Team, Lusiana Siti Masytoh on Wednesday (1/11). The event was attended by the Ministry of Health, HTA Agents and representatives of Universities, such as CEEBM RSCM, CHEPS FKM University of Indonesia, Faculty of Pharmacy University of Indonesia, CHES Muhammadiyah University of Purwokerto, Airlangga University, Padjadjaran University, Sebelas Maret State University, Diponegoro University, Lambung Mangkurat University, Sriwijaya University, and representatives of development partners (WHO and USAID-MTaPS).
The aim of increasing HTA capacity is to provide an overview of HTA implementation to other HTA agents, as well as to increase the capacity of HTA agents in terms of modeling and implementation. Real World Data (RWD). In addition to discussing the implementation of HTA in general, an overview of the economic evaluation was also presented, systematic review and meta-analysis, costing, calibration of the Markov transition probability of the model, and budget impact analysis.
The implementation of calibration in the implementation of HTA Economic Evaluation of Adjuvant Trastuzumab Administration in Patients with Early Stage HER2-positive Breast Cancer is a new breakthrough in the implementation of HTA in Indonesia. In the implementation of the calibration, survival data obtained from the Indonesian cancer registry data were used. The implementation of this calibration is an effort that is considered important and has the opportunity to be implemented in the implementation of the next HTA because it is in line with its goal to be able to produce HTA outputs that are closer to the conditions of Indonesian patients.
Along with the increasing number of HTA requests in Indonesia, this activity is expected to increase the capacity of HTA agents and can attract universities interested in becoming HTA agents in Indonesia. (Pusjak PDK BKPK)
